Dupont Capital Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Dupont Capital Management’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,333	Closed	-$190K	–	2014
2021 Q2	$190K	Hold	13,333	–	–	﹤0.01%	1311
2021 Q1	$56K	Hold	13,333	–	–	﹤0.01%	1419
2020 Q4	$75K	Buy	+13,333	New	+$53.8K	﹤0.01%	1227

Dupont Capital Management's CEREW Position: Q3 2021 in Review

Dupont Capital Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 13,333 shares — an estimated $190K sold.

Dupont Capital Management first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $190K in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Dupont Capital Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Dupont Capital Management sold 13,333 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $190K.
Dupont Capital Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
Dupont Capital Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $190K in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Dupont Capital Management's 13F filing for Q3 2021, filed 3 Nov 2021.